// App-Quantinova.ai

945 : Autoantibodies to the hPOP1 and Rpp25/38 Components of the Th/to Complex Identify a Subgroup of Systemic Sclerosis (SSc) Associated Interstitial Lung Disease (ILD) and Antibodies to hPOP1 Are Associated with Reduced Survival

Researchers

Presenter

  • Jennifer G Walker

Principal Investigators

  • Molla Huq

  • Karen Patterson

  • Peter Roberts-Thomson

  • Susanna Proudman

  • Wendy Stevens

  • Susan Lester

  • Maureen Rischmueller

  • Jane Zochling

  • Joanne Sahhar

  • Peter Nash

  • Janet Roddy

  • Catherine Hill

  • Marie Hudson

  • Murray Baron

  • Janet E. Pope

  • Maureen D. Mayes

  • Shervin Assassi

  • Michael Mahler

  • Marvin J. Fritzler

Medical Centers

  • University of South Australia, Adelaide, Australia

  • Deakin University, Melbourne, Australia

  • Department of Medicine (Rheumatology), Melbourne University, Melbourne, Australia

  • Immunology, Flinders University of South Australia, Adelaide, Australia

  • University of Adelaide, Adelaide, Australia

  • Rheumatology, St. Vincents Hospital, Melbourne, Australia

  • Queen Elizabeth Hospital, Adelaide, Australia

  • University of Adelaide, Adelaide, Australia

  • Menzies Institute of Medical Research, Hobart, Australia

  • Department of Rheumatology, Monash Medical Centre, Melbourne, Australia

  • The University of Queensland, Brisbane, Australia

  • Royal Perth Hospital, Perth, WA, Australia

  • School of Medicine, University of Adelaide, Adelaide, Australia

  • Division of Rheumatology, Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, QC, Canada

  • Medicine, McGill University, Quebec, Montreal, QC, Canada

  • Department of Medicine, Division of Rheumatology, University of Western Ontario, St. Joseph’s Health Care, London, ON, Canada,

  • Internal Medicine, Univ of Texas Health Science Cntr at Houston Med Sch, Houston, TX

  • University of Texas Medical School, Houston, TX.

  • Research and Development, Inova Diagnostics, San Diego, CA, United States

  • Internal Medicine, University of Calgary, Calgary, AB, Canada

Locations

  • Australia

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved